NCT01429623 / 2011-004187-30: A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment |
|
|
| Completed | 2 | 210 | Europe, RoW | ladostigil hemitartrate, ladostigil, Ladostigil capsules, Placebo | Avraham Pharmaceuticals Ltd | Mild Cognitive Impairment, Dementia | 07/16 | 09/16 | | |
